In MCF-7 breast cancer cells, CBP-mediated acetylation and its effect on survivin deacetylation suggest that HDAC6’s subcellular localisation can be altered through interactions with acetyltransferase proteins and by regulating its binding with other protein partners. This evidence concerns the gene BIRC5 and breast cancer.